Laure Belmondo

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Research on molecular alteration process mechanisms leading to cancerogenesis permitted the elaboration of many targeted therapies. Some therapeutic classes appeared recently and are currently being tested, including HER-2 dimerization inhibitors. However, most of these therapies are mostly ineffective with monotherapy. Clinical trials are ongoing, testing(More)
  • 1